Acquired
Novo Nordisk (Ozempic)
Ben Gilbert
So manufacturers usually have to pay the PBM a rebate, which lowers the net price of the drug. even though the list price stays the same. So there's a sticker price, but then there's a rebate that, you know, once the PBM pays the sticker price, actually the drug manufacturer... How does any of this get past the DOJ? Great question.
0
💬
0
Comments
Log in to comment.
There are no comments yet.